EAST BRUNSWICK, N.J.--(EON: Enhanced Online News)--Cronus Pharma LLC, an emerging animal health company focused on the development and marketing of prescription pharmaceuticals to improve the lives and health of companion animals, announced the commercial launch of Clindamycin Hydrochloride Oral Liquid (25mg/20mL) in a 20mL bottle, a generic version of Antirobe Aquadrops®. Clindamycin hydrochloride oral liquid is FDA approved for use in cats and dogs, indicated for specific treatments of skin infections, deep wounds, abscesses, osteomyelitis and dental infections caused by susceptible strains of specific microorganisms.
The product is currently commercially available through the Cronus network of national and regional veterinary wholesalers and distributors.
Cronus’ clindamycin hydrochloride oral liquid is the first product launched from the portfolio of products acquired from a leading global pharmaceutical company in 2014. Cronus plans to introduce several additional key products from this acquisition as well as launch internally developed products over the next few quarters. Edward Neugeboren, Chief Strategy Officer of Cronus Pharma stated, “This product launch is a key corporate milestone for Cronus as it the first product launched from our large portfolio acquired in 2014. Importantly, we have expanded our product portfolio to five products, with plans to continue introducing numerous additional products over the coming quarters and beyond. We are proud of our efforts in building a reliable and scalable supply chain to support the needs of our clients. Furthermore, our strategy of investing in internally developing products coupled with acquiring products is achieving our goal of building a diversified portfolio of cost effective companion animal pharmaceuticals. Our growing product pipeline consists of over 20 products representing an addressable market approximating $350 million.”
Cronus firmly believes that pets, their owners and their veterinarians benefit from a marketplace with reliable generic alternatives to more costly branded pharmaceuticals. Cronus will continue to launch affordable veterinary pharmaceuticals into the companion animal market as development, licensing and acquisition projects mature.
Antirobe Aquadrops® is a registered trademark of Zoetis.
About Cronus Pharma
Cronus Pharma is an emerging privately held veterinary generic pharmaceutical company located in East Brunswick, New Jersey, dedicated to providing innovative and cost effective products to the animal health market. Our team of seasoned industry professionals have been intimately involved in the establishment, and growth of several pharmaceutical manufacturing and distribution firms in both the human and animal health pharmaceutical industries. Through our in house R&D and licensing, Cronus brings several differentiated generic products serving the companion animal markets. We have a growing portfolio of over 20 products having recently acquired a large product portfolio from one of the leading global pharmaceutical companies. We are dedicated to investing in research & development and have an extensive team of scientists developing innovative products. Several products are under development as well as pending FDA approval. Fully licensed in all 50 states to distribute pharmaceutical products, our products are accessible to all veterinarians and pet owners nationwide at major wholesalers and regional distributors. Our passionate team is committed to growing our business and being among the leading veterinary generic pharmaceutical companies in the country.
Additional information is available on the company's website at www.cronuspharma.com